Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Boehringer Ingelheim
Cantor Fitzgerald
Queensland Health
Harvard Business School
Healthtrust
Merck
Teva
Chinese Patent Office

Generated: April 24, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,753,013

« Back to Dashboard

Summary for Patent: 6,753,013
Title: Pharmaceutical composition
Abstract:A pharmaceutical composition for dermal use, wherein the composition has a first pharmacologically active component A consisting of at least one vitamin D or vitamin D analogue, and a second pharmacologically active component B consisting of at least one corticosteroid, wherein the difference between the maximum stability pH of said first component A and the maximum stability pH of said second component B is at least 1. The composition can also have at least one solvent component C, where component C is compounds of the general formula R.sup.3 (OCH.sub.2 C(R.sup.1)H).sub.x OR.sup.2 (I), wherein x is in the range of 2-60, R.sup.1 in each of the x units independently is H or CH.sub.3, R.sup.2 is straight chain or branched C.sub.1-20 alkyl or benzoyl, and R.sup.3 is H or phenylcarbonyloxy; di-(straight or branched)-C.sub.4-10 alkyl esters of C.sub.4 -C.sub.8 dicarboxylic acids; straight or branched C.sub.12-18 -alkyl benzoates; straight or branched C.sub.2-4 -alkyl esters of straight or branched C.sub.10-18 -alkanoic or -alkenoic acids; propylenglycol diesters with C.sub.8-14 -alkanoic acids; and branched primary C.sub.18-24 alkanols.
Inventor(s): Didriksen; Erik (Ballerup, DK), H.o slashed.y; Gert (Ballerup, DK)
Assignee: Leo Pharmaceutical Products, Ltd. A/S (Ballerup, DK)
Application Number:09/959,367
Patent Claim Types:
see list of patent claims
Composition; Compound; Use; Dosage form;

Drugs Protected by US Patent 6,753,013

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Leo Pharma As ENSTILAR betamethasone dipropionate; calcipotriene AEROSOL, FOAM;TOPICAL 207589-001 Oct 16, 2015 RX Yes Yes ➤ Sign Up ➤ Sign Up Y PLAQUE PSORIASIS ➤ Sign Up
Leo Pharma As TACLONEX betamethasone dipropionate; calcipotriene hydrate OINTMENT;TOPICAL 021852-001 Jan 9, 2006 AB RX Yes Yes ➤ Sign Up ➤ Sign Up Y TREATMENT OF MODERATE PLAQUE PSORIASIS ➤ Sign Up
Leo Pharma As TACLONEX betamethasone dipropionate; calcipotriene hydrate OINTMENT;TOPICAL 021852-001 Jan 9, 2006 AB RX Yes Yes ➤ Sign Up ➤ Sign Up Y PSORIASIS ➤ Sign Up
Leo Pharma As TACLONEX betamethasone dipropionate; calcipotriene hydrate SUSPENSION;TOPICAL 022185-001 May 9, 2008 RX Yes Yes ➤ Sign Up ➤ Sign Up Y PSORIASIS ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 6,753,013

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Denmark1999 00561Apr 23, 1999
PCT Information
PCT FiledJanuary 27, 2000PCT Application Number:PCT/DK00/00033
PCT Publication Date:November 02, 2000PCT Publication Number: WO00/64450

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Deloitte
US Army
Medtronic
Cantor Fitzgerald
Farmers Insurance
Johnson and Johnson
Fuji
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.